203 related articles for article (PubMed ID: 21335972)
1. Dementia risk score predicts cognitive impairment after a period of 15 years in a nondemented population.
Reijmer YD; van den Berg E; van Sonsbeek S; Dekker JM; Nijpels G; Stehouwer CD; Kappelle LJ; Biessels GJ
Dement Geriatr Cogn Disord; 2011; 31(2):152-7. PubMed ID: 21335972
[TBL] [Abstract][Full Text] [Related]
2. Conversion of mild cognitive impairment to dementia in elderly subjects: a preliminary study in a memory and cognitive disorder unit.
Maioli F; Coveri M; Pagni P; Chiandetti C; Marchetti C; Ciarrocchi R; Ruggero C; Nativio V; Onesti A; D'Anastasio C; Pedone V
Arch Gerontol Geriatr; 2007; 44 Suppl 1():233-41. PubMed ID: 17317458
[TBL] [Abstract][Full Text] [Related]
3. [Cognitive impairment and cardiovascular disease risk factors. Project CASCADE Kraków. I. Project to test exposure to risk factors for cardiovascular disease in the studied sample].
Pajak A; Kawalec E; Szczudlik A
Przegl Lek; 1998; 55(12):676-82. PubMed ID: 10354721
[TBL] [Abstract][Full Text] [Related]
4. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.
Rozzini L; Chilovi BV; Conti M; Bertoletti E; Delrio I; Trabucchi M; Padovani A
Int J Geriatr Psychiatry; 2007 Dec; 22(12):1217-22. PubMed ID: 17562522
[TBL] [Abstract][Full Text] [Related]
5. Combined memory and executive function tests can screen mild cognitive impairment and converters to dementia in a community: the Osaki-Tajiri project.
Nakata E; Kasai M; Kasuya M; Akanuma K; Meguro M; Ishii H; Yamaguchi S; Meguro K
Neuroepidemiology; 2009; 33(2):103-10. PubMed ID: 19494551
[TBL] [Abstract][Full Text] [Related]
6. Development of vascular risk factors over 15 years in relation to cognition: the Hoorn Study.
Reijmer YD; van den Berg E; Dekker JM; Nijpels G; Stehouwer CD; Kappelle LJ; Biessels GJ
J Am Geriatr Soc; 2012 Aug; 60(8):1426-33. PubMed ID: 22861348
[TBL] [Abstract][Full Text] [Related]
7. [Depression and frontal dysfunction: risks for the elderly?].
Thomas P; Hazif Thomas C; Billon R; Peix R; Faugeron P; Clément JP
Encephale; 2009 Sep; 35(4):361-9. PubMed ID: 19748373
[TBL] [Abstract][Full Text] [Related]
8. Ankle brachial index as a predictor of cognitive impairment in the general population: ten-year follow-up of the Edinburgh Artery Study.
Price JF; McDowell S; Whiteman MC; Deary IJ; Stewart MC; Fowkes FG
J Am Geriatr Soc; 2006 May; 54(5):763-9. PubMed ID: 16696741
[TBL] [Abstract][Full Text] [Related]
9. Does anxiety affect risk of dementia? Findings from the Caerphilly Prospective Study.
Gallacher J; Bayer A; Fish M; Pickering J; Pedro S; Dunstan F; Ebrahim S; Ben-Shlomo Y
Psychosom Med; 2009 Jul; 71(6):659-66. PubMed ID: 19553290
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment.
Rozzini L; Chilovi BV; Bertoletti E; Conti M; Del Rio I; Trabucchi M; Padovani A
Int J Geriatr Psychiatry; 2006 Jun; 21(6):550-5. PubMed ID: 16642542
[TBL] [Abstract][Full Text] [Related]
11. Cognitive impairment and dementia after intracerebral hemorrhage: a cross-sectional study of a hospital-based series.
Garcia PY; Roussel M; Bugnicourt JM; Lamy C; Canaple S; Peltier J; Loas G; Deramond H; Godefroy O
J Stroke Cerebrovasc Dis; 2013 Jan; 22(1):80-6. PubMed ID: 22421024
[TBL] [Abstract][Full Text] [Related]
12. B-type natriuretic peptide as a predictor of declining cognitive function and dementia--a cohort study of an elderly general population with a 5-year follow-up.
Kerola T; Nieminen T; Hartikainen S; Sulkava R; Vuolteenaho O; Kettunen R
Ann Med; 2010 Apr; 42(3):207-15. PubMed ID: 20384435
[TBL] [Abstract][Full Text] [Related]
13. Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study.
Solomon A; Kåreholt I; Ngandu T; Winblad B; Nissinen A; Tuomilehto J; Soininen H; Kivipelto M
Neurology; 2007 Mar; 68(10):751-6. PubMed ID: 17339582
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and patterns of cognitive impairment in sporadic ALS.
Ringholz GM; Appel SH; Bradshaw M; Cooke NA; Mosnik DM; Schulz PE
Neurology; 2005 Aug; 65(4):586-90. PubMed ID: 16116120
[TBL] [Abstract][Full Text] [Related]
15. Serum uric acid and cognitive function and dementia.
Euser SM; Hofman A; Westendorp RG; Breteler MM
Brain; 2009 Feb; 132(Pt 2):377-82. PubMed ID: 19036766
[TBL] [Abstract][Full Text] [Related]
16. The metabolic syndrome, atherosclerosis and cognitive functioning in a non-demented population: the Hoorn Study.
Reijmer YD; van den Berg E; Dekker JM; Nijpels G; Stehouwer CD; Kappelle LJ; Biessels GJ
Atherosclerosis; 2011 Dec; 219(2):839-45. PubMed ID: 21959256
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of mild cognitive impairment for dementia. The influence of case definition and age.
Baars MA; van Boxtel MP; Dijkstra JB; Visser PJ; van den Akker M; Verhey FR; Jolles J
Dement Geriatr Cogn Disord; 2009; 27(2):173-81. PubMed ID: 19202336
[TBL] [Abstract][Full Text] [Related]
18. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
19. Neuropsychological measures in normal individuals that predict subsequent cognitive decline.
Blacker D; Lee H; Muzikansky A; Martin EC; Tanzi R; McArdle JJ; Moss M; Albert M
Arch Neurol; 2007 Jun; 64(6):862-71. PubMed ID: 17562935
[TBL] [Abstract][Full Text] [Related]
20. Neuropathology of older persons without cognitive impairment from two community-based studies.
Bennett DA; Schneider JA; Arvanitakis Z; Kelly JF; Aggarwal NT; Shah RC; Wilson RS
Neurology; 2006 Jun; 66(12):1837-44. PubMed ID: 16801647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
